Received Jun 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | X012268 | — |
No side effects or symptoms reported; HCP called to report a patient received an expired dose of VARIVAX. The product expired 04/30/2025 and was administered 06/02/2025. Caller verified the product has not had any temperature excursions. No side effects or symptoms reported. No addition; This spontaneous report was received from a medical assistant and refers to a 5-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 02-Jun-2025, the patient was vaccinated with an expired dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #X012268, expiration date: 30-Apr-2025), dose number 1, 0.5 mL, that was reconstituted with sterile diluent for prophylaxis (expired product administered). No adverse event was reported.
Sterile diluent